Our results related to renal markers can support the hypothesis previously driven about the AAT as a biomarker of renal disease, and probably be of importance in the SCD patients, although it has not been studied yet with this focus, but we believe it will bring countless benefits for this group of patients. Here, SERPINA1 is linked to kidney disorder.